nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinorelbine—Vinca Alkaloids—Vincristine—colon cancer	0.284	1	CiPCiCtD
Vinorelbine—Vincristine—colon cancer	0.216	1	CrCtD
Vinorelbine—breast cancer—colon cancer	0.0681	0.408	CtDrD
Vinorelbine—ovarian cancer—colon cancer	0.0547	0.328	CtDrD
Vinorelbine—Vindesine—Vincristine—colon cancer	0.0509	0.379	CrCrCtD
Vinorelbine—Vinblastine—Vincristine—colon cancer	0.0509	0.379	CrCrCtD
Vinorelbine—lung cancer—colon cancer	0.0442	0.265	CtDrD
Vinorelbine—ABCB1—colon cancer	0.0379	1	CbGaD
Vinorelbine—Voacamine—Vincristine—colon cancer	0.0325	0.242	CrCrCtD
Vinorelbine—TUBB2A—Vincristine—colon cancer	0.0151	0.114	CbGbCtD
Vinorelbine—TUBB2B—Vincristine—colon cancer	0.0151	0.114	CbGbCtD
Vinorelbine—TUBB4A—Vincristine—colon cancer	0.0151	0.114	CbGbCtD
Vinorelbine—TUBB3—Vincristine—colon cancer	0.0151	0.114	CbGbCtD
Vinorelbine—TUBB6—Vincristine—colon cancer	0.0151	0.114	CbGbCtD
Vinorelbine—TUBB8—Vincristine—colon cancer	0.0151	0.114	CbGbCtD
Vinorelbine—TUBB—Vincristine—colon cancer	0.0126	0.0956	CbGbCtD
Vinorelbine—TUBB1—Vincristine—colon cancer	0.0126	0.0956	CbGbCtD
Vinorelbine—TUBB4B—Vincristine—colon cancer	0.0126	0.0956	CbGbCtD
Vinorelbine—ABCB1—Irinotecan—colon cancer	0.00103	0.00779	CbGbCtD
Vinorelbine—ABCB1—Vincristine—colon cancer	0.000896	0.0068	CbGbCtD
Vinorelbine—CYP3A4—Irinotecan—colon cancer	0.000614	0.00466	CbGbCtD
Vinorelbine—ABCB1—Methotrexate—colon cancer	0.000543	0.00412	CbGbCtD
Vinorelbine—CYP3A4—Vincristine—colon cancer	0.000537	0.00408	CbGbCtD
Vinorelbine—TUBB3—lymphoid tissue—colon cancer	0.000237	0.0385	CbGeAlD
Vinorelbine—TUBB3—digestive system—colon cancer	0.000235	0.038	CbGeAlD
Vinorelbine—TUBB4A—embryo—colon cancer	0.00023	0.0373	CbGeAlD
Vinorelbine—TUBB1—bone marrow—colon cancer	0.000211	0.0343	CbGeAlD
Vinorelbine—Voacamine—ABCB1—colon cancer	0.000204	0.586	CrCbGaD
Vinorelbine—TUBB4B—embryo—colon cancer	0.000179	0.0291	CbGeAlD
Vinorelbine—TUBB4A—renal system—colon cancer	0.000174	0.0282	CbGeAlD
Vinorelbine—TUBB6—epithelium—colon cancer	0.000168	0.0273	CbGeAlD
Vinorelbine—TUBB2B—renal system—colon cancer	0.000168	0.0273	CbGeAlD
Vinorelbine—TUBB—smooth muscle tissue—colon cancer	0.000165	0.0268	CbGeAlD
Vinorelbine—TUBB2A—smooth muscle tissue—colon cancer	0.000164	0.0267	CbGeAlD
Vinorelbine—TUBB6—smooth muscle tissue—colon cancer	0.000162	0.0263	CbGeAlD
Vinorelbine—TUBB6—renal system—colon cancer	0.000156	0.0253	CbGeAlD
Vinorelbine—TUBB4A—lymphoid tissue—colon cancer	0.000144	0.0234	CbGeAlD
Vinorelbine—TUBB4A—digestive system—colon cancer	0.000143	0.0231	CbGeAlD
Vinorelbine—TUBB4B—smooth muscle tissue—colon cancer	0.000141	0.0229	CbGeAlD
Vinorelbine—TUBB2B—digestive system—colon cancer	0.000138	0.0224	CbGeAlD
Vinorelbine—TUBB4B—renal system—colon cancer	0.000136	0.022	CbGeAlD
Vinorelbine—TUBB2A—digestive system—colon cancer	0.00013	0.021	CbGeAlD
Vinorelbine—TUBB6—lymphoid tissue—colon cancer	0.00013	0.021	CbGeAlD
Vinorelbine—TUBB6—digestive system—colon cancer	0.000128	0.0208	CbGeAlD
Vinorelbine—TUBB2B—vagina—colon cancer	0.000122	0.0197	CbGeAlD
Vinorelbine—TUBB—bone marrow—colon cancer	0.00012	0.0195	CbGeAlD
Vinorelbine—TUBB2A—bone marrow—colon cancer	0.00012	0.0194	CbGeAlD
Vinorelbine—TUBB6—bone marrow—colon cancer	0.000118	0.0191	CbGeAlD
Vinorelbine—TUBB—vagina—colon cancer	0.000115	0.0187	CbGeAlD
Vinorelbine—TUBB2A—vagina—colon cancer	0.000115	0.0186	CbGeAlD
Vinorelbine—TUBB6—vagina—colon cancer	0.000113	0.0183	CbGeAlD
Vinorelbine—TUBB4B—lymphoid tissue—colon cancer	0.000113	0.0183	CbGeAlD
Vinorelbine—TUBB4B—digestive system—colon cancer	0.000111	0.018	CbGeAlD
Vinorelbine—TUBB4A—liver—colon cancer	0.000106	0.0172	CbGeAlD
Vinorelbine—TUBB4B—bone marrow—colon cancer	0.000103	0.0166	CbGeAlD
Vinorelbine—TUBB4B—vagina—colon cancer	9.83e-05	0.0159	CbGeAlD
Vinorelbine—TUBB—liver—colon cancer	9.73e-05	0.0158	CbGeAlD
Vinorelbine—TUBB2A—liver—colon cancer	9.67e-05	0.0157	CbGeAlD
Vinorelbine—TUBB6—liver—colon cancer	9.54e-05	0.0155	CbGeAlD
Vinorelbine—ABCB1—blood vessel—colon cancer	8.74e-05	0.0142	CbGeAlD
Vinorelbine—TUBB4B—liver—colon cancer	8.29e-05	0.0134	CbGeAlD
Vinorelbine—TUBB4A—lymph node—colon cancer	8.15e-05	0.0132	CbGeAlD
Vinorelbine—TUBB2B—lymph node—colon cancer	7.88e-05	0.0128	CbGeAlD
Vinorelbine—TUBB—lymph node—colon cancer	7.46e-05	0.0121	CbGeAlD
Vinorelbine—TUBB2A—lymph node—colon cancer	7.42e-05	0.012	CbGeAlD
Vinorelbine—TUBB6—lymph node—colon cancer	7.32e-05	0.0119	CbGeAlD
Vinorelbine—Vinblastine—ABCB1—colon cancer	7.29e-05	0.209	CrCbGaD
Vinorelbine—Vincristine—ABCB1—colon cancer	7.16e-05	0.205	CrCbGaD
Vinorelbine—TUBB4B—lymph node—colon cancer	6.36e-05	0.0103	CbGeAlD
Vinorelbine—CYP3A4—renal system—colon cancer	5.58e-05	0.00904	CbGeAlD
Vinorelbine—CYP2D6—renal system—colon cancer	5.49e-05	0.00889	CbGeAlD
Vinorelbine—ABCB1—embryo—colon cancer	5.22e-05	0.00845	CbGeAlD
Vinorelbine—CYP3A4—digestive system—colon cancer	4.57e-05	0.00741	CbGeAlD
Vinorelbine—CYP2D6—digestive system—colon cancer	4.5e-05	0.0073	CbGeAlD
Vinorelbine—ABCB1—epithelium—colon cancer	4.26e-05	0.0069	CbGeAlD
Vinorelbine—Cardiac disorder—Vincristine—colon cancer	4.22e-05	0.00188	CcSEcCtD
Vinorelbine—Hypoaesthesia—Fluorouracil—colon cancer	4.22e-05	0.00188	CcSEcCtD
Vinorelbine—Skin exfoliation—Methotrexate—colon cancer	4.2e-05	0.00187	CcSEcCtD
Vinorelbine—Angiopathy—Vincristine—colon cancer	4.13e-05	0.00184	CcSEcCtD
Vinorelbine—Aplastic anaemia—Methotrexate—colon cancer	4.13e-05	0.00184	CcSEcCtD
Vinorelbine—Cardiac disorder—Irinotecan—colon cancer	4.11e-05	0.00183	CcSEcCtD
Vinorelbine—Flushing—Irinotecan—colon cancer	4.11e-05	0.00183	CcSEcCtD
Vinorelbine—Mediastinal disorder—Vincristine—colon cancer	4.1e-05	0.00183	CcSEcCtD
Vinorelbine—Alopecia—Vincristine—colon cancer	4.02e-05	0.00179	CcSEcCtD
Vinorelbine—Angiopathy—Irinotecan—colon cancer	4.02e-05	0.00179	CcSEcCtD
Vinorelbine—Blood creatinine increased—Capecitabine—colon cancer	4.02e-05	0.00179	CcSEcCtD
Vinorelbine—Immune system disorder—Irinotecan—colon cancer	4e-05	0.00178	CcSEcCtD
Vinorelbine—Mediastinal disorder—Irinotecan—colon cancer	3.99e-05	0.00178	CcSEcCtD
Vinorelbine—Arrhythmia—Irinotecan—colon cancer	3.96e-05	0.00176	CcSEcCtD
Vinorelbine—ABCB1—renal system—colon cancer	3.95e-05	0.0064	CbGeAlD
Vinorelbine—Alopecia—Irinotecan—colon cancer	3.92e-05	0.00174	CcSEcCtD
Vinorelbine—Pulmonary oedema—Methotrexate—colon cancer	3.91e-05	0.00174	CcSEcCtD
Vinorelbine—Aspartate aminotransferase increased—Capecitabine—colon cancer	3.86e-05	0.00172	CcSEcCtD
Vinorelbine—Back pain—Vincristine—colon cancer	3.83e-05	0.00171	CcSEcCtD
Vinorelbine—Sepsis—Methotrexate—colon cancer	3.82e-05	0.0017	CcSEcCtD
Vinorelbine—Arrhythmia—Fluorouracil—colon cancer	3.79e-05	0.00169	CcSEcCtD
Vinorelbine—Muscular weakness—Capecitabine—colon cancer	3.78e-05	0.00168	CcSEcCtD
Vinorelbine—Alopecia—Fluorouracil—colon cancer	3.75e-05	0.00167	CcSEcCtD
Vinorelbine—Back pain—Irinotecan—colon cancer	3.73e-05	0.00166	CcSEcCtD
Vinorelbine—Dysphagia—Capecitabine—colon cancer	3.71e-05	0.00165	CcSEcCtD
Vinorelbine—Erythema—Fluorouracil—colon cancer	3.69e-05	0.00165	CcSEcCtD
Vinorelbine—Thrombophlebitis—Methotrexate—colon cancer	3.69e-05	0.00164	CcSEcCtD
Vinorelbine—Anaemia—Vincristine—colon cancer	3.66e-05	0.00163	CcSEcCtD
Vinorelbine—Bronchospasm—Capecitabine—colon cancer	3.64e-05	0.00162	CcSEcCtD
Vinorelbine—Polyuria—Methotrexate—colon cancer	3.63e-05	0.00162	CcSEcCtD
Vinorelbine—Angina pectoris—Capecitabine—colon cancer	3.61e-05	0.00161	CcSEcCtD
Vinorelbine—Ill-defined disorder—Irinotecan—colon cancer	3.58e-05	0.00159	CcSEcCtD
Vinorelbine—Anaemia—Irinotecan—colon cancer	3.57e-05	0.00159	CcSEcCtD
Vinorelbine—Vertigo—Vincristine—colon cancer	3.56e-05	0.00158	CcSEcCtD
Vinorelbine—Hepatic failure—Methotrexate—colon cancer	3.55e-05	0.00158	CcSEcCtD
Vinorelbine—Leukopenia—Vincristine—colon cancer	3.55e-05	0.00158	CcSEcCtD
Vinorelbine—Pancytopenia—Capecitabine—colon cancer	3.52e-05	0.00157	CcSEcCtD
Vinorelbine—Malaise—Irinotecan—colon cancer	3.48e-05	0.00155	CcSEcCtD
Vinorelbine—Vertigo—Irinotecan—colon cancer	3.47e-05	0.00154	CcSEcCtD
Vinorelbine—Neutropenia—Capecitabine—colon cancer	3.47e-05	0.00154	CcSEcCtD
Vinorelbine—Leukopenia—Irinotecan—colon cancer	3.45e-05	0.00154	CcSEcCtD
Vinorelbine—Hypertension—Vincristine—colon cancer	3.42e-05	0.00152	CcSEcCtD
Vinorelbine—Anaemia—Fluorouracil—colon cancer	3.41e-05	0.00152	CcSEcCtD
Vinorelbine—CYP3A4—liver—colon cancer	3.41e-05	0.00552	CbGeAlD
Vinorelbine—Myalgia—Vincristine—colon cancer	3.37e-05	0.0015	CcSEcCtD
Vinorelbine—Cough—Irinotecan—colon cancer	3.37e-05	0.0015	CcSEcCtD
Vinorelbine—CYP2D6—liver—colon cancer	3.35e-05	0.00543	CbGeAlD
Vinorelbine—Weight decreased—Capecitabine—colon cancer	3.35e-05	0.00149	CcSEcCtD
Vinorelbine—Hypertension—Irinotecan—colon cancer	3.33e-05	0.00148	CcSEcCtD
Vinorelbine—Pneumonia—Capecitabine—colon cancer	3.32e-05	0.00148	CcSEcCtD
Vinorelbine—Leukopenia—Fluorouracil—colon cancer	3.31e-05	0.00147	CcSEcCtD
Vinorelbine—Infestation NOS—Capecitabine—colon cancer	3.3e-05	0.00147	CcSEcCtD
Vinorelbine—Infestation—Capecitabine—colon cancer	3.3e-05	0.00147	CcSEcCtD
Vinorelbine—ABCB1—lymphoid tissue—colon cancer	3.28e-05	0.00531	CbGeAlD
Vinorelbine—Acute coronary syndrome—Capecitabine—colon cancer	3.26e-05	0.00145	CcSEcCtD
Vinorelbine—Cerebrovascular accident—Methotrexate—colon cancer	3.26e-05	0.00145	CcSEcCtD
Vinorelbine—Lethargy—Methotrexate—colon cancer	3.26e-05	0.00145	CcSEcCtD
Vinorelbine—Discomfort—Irinotecan—colon cancer	3.24e-05	0.00144	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Capecitabine—colon cancer	3.24e-05	0.00144	CcSEcCtD
Vinorelbine—Myocardial infarction—Capecitabine—colon cancer	3.24e-05	0.00144	CcSEcCtD
Vinorelbine—ABCB1—digestive system—colon cancer	3.24e-05	0.00525	CbGeAlD
Vinorelbine—Anaphylactic shock—Vincristine—colon cancer	3.23e-05	0.00144	CcSEcCtD
Vinorelbine—Stomatitis—Capecitabine—colon cancer	3.22e-05	0.00143	CcSEcCtD
Vinorelbine—Infection—Vincristine—colon cancer	3.21e-05	0.00143	CcSEcCtD
Vinorelbine—Nervous system disorder—Vincristine—colon cancer	3.17e-05	0.00141	CcSEcCtD
Vinorelbine—Thrombocytopenia—Vincristine—colon cancer	3.17e-05	0.00141	CcSEcCtD
Vinorelbine—Anaphylactic shock—Irinotecan—colon cancer	3.15e-05	0.0014	CcSEcCtD
Vinorelbine—Myalgia—Fluorouracil—colon cancer	3.15e-05	0.0014	CcSEcCtD
Vinorelbine—Chest pain—Fluorouracil—colon cancer	3.15e-05	0.0014	CcSEcCtD
Vinorelbine—Infection—Irinotecan—colon cancer	3.13e-05	0.00139	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Capecitabine—colon cancer	3.12e-05	0.00139	CcSEcCtD
Vinorelbine—Discomfort—Fluorouracil—colon cancer	3.11e-05	0.00138	CcSEcCtD
Vinorelbine—Nervous system disorder—Irinotecan—colon cancer	3.09e-05	0.00137	CcSEcCtD
Vinorelbine—Agranulocytosis—Capecitabine—colon cancer	3.08e-05	0.00137	CcSEcCtD
Vinorelbine—Thrombocytopenia—Irinotecan—colon cancer	3.08e-05	0.00137	CcSEcCtD
Vinorelbine—Anorexia—Vincristine—colon cancer	3.08e-05	0.00137	CcSEcCtD
Vinorelbine—Hypotension—Vincristine—colon cancer	3.02e-05	0.00135	CcSEcCtD
Vinorelbine—Anaphylactic shock—Fluorouracil—colon cancer	3.02e-05	0.00134	CcSEcCtD
Vinorelbine—Anorexia—Irinotecan—colon cancer	3e-05	0.00134	CcSEcCtD
Vinorelbine—Infection—Fluorouracil—colon cancer	3e-05	0.00133	CcSEcCtD
Vinorelbine—ABCB1—bone marrow—colon cancer	2.98e-05	0.00484	CbGeAlD
Vinorelbine—Nervous system disorder—Fluorouracil—colon cancer	2.96e-05	0.00132	CcSEcCtD
Vinorelbine—Thrombocytopenia—Fluorouracil—colon cancer	2.95e-05	0.00131	CcSEcCtD
Vinorelbine—Hypoaesthesia—Capecitabine—colon cancer	2.95e-05	0.00131	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Vincristine—colon cancer	2.95e-05	0.00131	CcSEcCtD
Vinorelbine—Tachycardia—Fluorouracil—colon cancer	2.94e-05	0.00131	CcSEcCtD
Vinorelbine—Hypotension—Irinotecan—colon cancer	2.94e-05	0.00131	CcSEcCtD
Vinorelbine—Connective tissue disorder—Capecitabine—colon cancer	2.91e-05	0.0013	CcSEcCtD
Vinorelbine—Paraesthesia—Vincristine—colon cancer	2.9e-05	0.00129	CcSEcCtD
Vinorelbine—Anorexia—Fluorouracil—colon cancer	2.87e-05	0.00128	CcSEcCtD
Vinorelbine—ABCB1—vagina—colon cancer	2.86e-05	0.00463	CbGeAlD
Vinorelbine—Paraesthesia—Irinotecan—colon cancer	2.83e-05	0.00126	CcSEcCtD
Vinorelbine—Hypotension—Fluorouracil—colon cancer	2.82e-05	0.00125	CcSEcCtD
Vinorelbine—Decreased appetite—Vincristine—colon cancer	2.81e-05	0.00125	CcSEcCtD
Vinorelbine—Dyspnoea—Irinotecan—colon cancer	2.81e-05	0.00125	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Vincristine—colon cancer	2.79e-05	0.00124	CcSEcCtD
Vinorelbine—Fatigue—Vincristine—colon cancer	2.79e-05	0.00124	CcSEcCtD
Vinorelbine—Constipation—Vincristine—colon cancer	2.76e-05	0.00123	CcSEcCtD
Vinorelbine—Pain—Vincristine—colon cancer	2.76e-05	0.00123	CcSEcCtD
Vinorelbine—Flushing—Capecitabine—colon cancer	2.75e-05	0.00123	CcSEcCtD
Vinorelbine—Cardiac disorder—Capecitabine—colon cancer	2.75e-05	0.00123	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Fluorouracil—colon cancer	2.75e-05	0.00122	CcSEcCtD
Vinorelbine—Decreased appetite—Irinotecan—colon cancer	2.74e-05	0.00122	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Irinotecan—colon cancer	2.72e-05	0.00121	CcSEcCtD
Vinorelbine—Fatigue—Irinotecan—colon cancer	2.71e-05	0.00121	CcSEcCtD
Vinorelbine—Paraesthesia—Fluorouracil—colon cancer	2.71e-05	0.00121	CcSEcCtD
Vinorelbine—Pancreatitis—Methotrexate—colon cancer	2.7e-05	0.0012	CcSEcCtD
Vinorelbine—Constipation—Irinotecan—colon cancer	2.69e-05	0.0012	CcSEcCtD
Vinorelbine—Pain—Irinotecan—colon cancer	2.69e-05	0.0012	CcSEcCtD
Vinorelbine—Angiopathy—Capecitabine—colon cancer	2.69e-05	0.0012	CcSEcCtD
Vinorelbine—Dyspnoea—Fluorouracil—colon cancer	2.69e-05	0.0012	CcSEcCtD
Vinorelbine—Immune system disorder—Capecitabine—colon cancer	2.68e-05	0.00119	CcSEcCtD
Vinorelbine—Mediastinal disorder—Capecitabine—colon cancer	2.67e-05	0.00119	CcSEcCtD
Vinorelbine—Arrhythmia—Capecitabine—colon cancer	2.65e-05	0.00118	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Vincristine—colon cancer	2.64e-05	0.00118	CcSEcCtD
Vinorelbine—Decreased appetite—Fluorouracil—colon cancer	2.62e-05	0.00117	CcSEcCtD
Vinorelbine—Alopecia—Capecitabine—colon cancer	2.62e-05	0.00117	CcSEcCtD
Vinorelbine—Pancytopenia—Methotrexate—colon cancer	2.62e-05	0.00117	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Fluorouracil—colon cancer	2.6e-05	0.00116	CcSEcCtD
Vinorelbine—Feeling abnormal—Irinotecan—colon cancer	2.59e-05	0.00116	CcSEcCtD
Vinorelbine—Malnutrition—Capecitabine—colon cancer	2.58e-05	0.00115	CcSEcCtD
Vinorelbine—Erythema—Capecitabine—colon cancer	2.58e-05	0.00115	CcSEcCtD
Vinorelbine—Neutropenia—Methotrexate—colon cancer	2.58e-05	0.00115	CcSEcCtD
Vinorelbine—Pain—Fluorouracil—colon cancer	2.58e-05	0.00115	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Irinotecan—colon cancer	2.57e-05	0.00115	CcSEcCtD
Vinorelbine—Abdominal pain—Vincristine—colon cancer	2.56e-05	0.00114	CcSEcCtD
Vinorelbine—Body temperature increased—Vincristine—colon cancer	2.56e-05	0.00114	CcSEcCtD
Vinorelbine—Back pain—Capecitabine—colon cancer	2.5e-05	0.00111	CcSEcCtD
Vinorelbine—Abdominal pain—Irinotecan—colon cancer	2.49e-05	0.00111	CcSEcCtD
Vinorelbine—Body temperature increased—Irinotecan—colon cancer	2.49e-05	0.00111	CcSEcCtD
Vinorelbine—Feeling abnormal—Fluorouracil—colon cancer	2.48e-05	0.00111	CcSEcCtD
Vinorelbine—Pneumonia—Methotrexate—colon cancer	2.47e-05	0.0011	CcSEcCtD
Vinorelbine—Infestation—Methotrexate—colon cancer	2.46e-05	0.0011	CcSEcCtD
Vinorelbine—Infestation NOS—Methotrexate—colon cancer	2.46e-05	0.0011	CcSEcCtD
Vinorelbine—ABCB1—liver—colon cancer	2.41e-05	0.00391	CbGeAlD
Vinorelbine—Stomatitis—Methotrexate—colon cancer	2.4e-05	0.00107	CcSEcCtD
Vinorelbine—Ill-defined disorder—Capecitabine—colon cancer	2.4e-05	0.00107	CcSEcCtD
Vinorelbine—Urticaria—Fluorouracil—colon cancer	2.4e-05	0.00107	CcSEcCtD
Vinorelbine—Anaemia—Capecitabine—colon cancer	2.39e-05	0.00106	CcSEcCtD
Vinorelbine—Body temperature increased—Fluorouracil—colon cancer	2.38e-05	0.00106	CcSEcCtD
Vinorelbine—Hypersensitivity—Vincristine—colon cancer	2.38e-05	0.00106	CcSEcCtD
Vinorelbine—Malaise—Capecitabine—colon cancer	2.33e-05	0.00104	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Methotrexate—colon cancer	2.33e-05	0.00104	CcSEcCtD
Vinorelbine—Vertigo—Capecitabine—colon cancer	2.32e-05	0.00103	CcSEcCtD
Vinorelbine—Hypersensitivity—Irinotecan—colon cancer	2.32e-05	0.00103	CcSEcCtD
Vinorelbine—Asthenia—Vincristine—colon cancer	2.32e-05	0.00103	CcSEcCtD
Vinorelbine—Leukopenia—Capecitabine—colon cancer	2.31e-05	0.00103	CcSEcCtD
Vinorelbine—Agranulocytosis—Methotrexate—colon cancer	2.3e-05	0.00102	CcSEcCtD
Vinorelbine—Palpitations—Capecitabine—colon cancer	2.28e-05	0.00102	CcSEcCtD
Vinorelbine—Asthenia—Irinotecan—colon cancer	2.26e-05	0.00101	CcSEcCtD
Vinorelbine—Cough—Capecitabine—colon cancer	2.25e-05	0.001	CcSEcCtD
Vinorelbine—Hypertension—Capecitabine—colon cancer	2.23e-05	0.000993	CcSEcCtD
Vinorelbine—Hypersensitivity—Fluorouracil—colon cancer	2.22e-05	0.000989	CcSEcCtD
Vinorelbine—Diarrhoea—Vincristine—colon cancer	2.21e-05	0.000985	CcSEcCtD
Vinorelbine—Arthralgia—Capecitabine—colon cancer	2.2e-05	0.000979	CcSEcCtD
Vinorelbine—Chest pain—Capecitabine—colon cancer	2.2e-05	0.000979	CcSEcCtD
Vinorelbine—Myalgia—Capecitabine—colon cancer	2.2e-05	0.000979	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	2.18e-05	0.000972	CcSEcCtD
Vinorelbine—Discomfort—Capecitabine—colon cancer	2.17e-05	0.000967	CcSEcCtD
Vinorelbine—Diarrhoea—Irinotecan—colon cancer	2.15e-05	0.000959	CcSEcCtD
Vinorelbine—Dizziness—Vincristine—colon cancer	2.14e-05	0.000952	CcSEcCtD
Vinorelbine—Pruritus—Fluorouracil—colon cancer	2.13e-05	0.00095	CcSEcCtD
Vinorelbine—Infection—Capecitabine—colon cancer	2.09e-05	0.000932	CcSEcCtD
Vinorelbine—Dizziness—Irinotecan—colon cancer	2.08e-05	0.000927	CcSEcCtD
Vinorelbine—Nervous system disorder—Capecitabine—colon cancer	2.07e-05	0.00092	CcSEcCtD
Vinorelbine—Diarrhoea—Fluorouracil—colon cancer	2.06e-05	0.000919	CcSEcCtD
Vinorelbine—Thrombocytopenia—Capecitabine—colon cancer	2.06e-05	0.000919	CcSEcCtD
Vinorelbine—Tachycardia—Capecitabine—colon cancer	2.06e-05	0.000916	CcSEcCtD
Vinorelbine—Vomiting—Vincristine—colon cancer	2.06e-05	0.000915	CcSEcCtD
Vinorelbine—Cardiac disorder—Methotrexate—colon cancer	2.05e-05	0.000912	CcSEcCtD
Vinorelbine—Skin disorder—Capecitabine—colon cancer	2.05e-05	0.000911	CcSEcCtD
Vinorelbine—Rash—Vincristine—colon cancer	2.04e-05	0.000908	CcSEcCtD
Vinorelbine—Dermatitis—Vincristine—colon cancer	2.04e-05	0.000907	CcSEcCtD
Vinorelbine—Headache—Vincristine—colon cancer	2.03e-05	0.000902	CcSEcCtD
Vinorelbine—Anorexia—Capecitabine—colon cancer	2.01e-05	0.000894	CcSEcCtD
Vinorelbine—Angiopathy—Methotrexate—colon cancer	2e-05	0.000892	CcSEcCtD
Vinorelbine—Vomiting—Irinotecan—colon cancer	2e-05	0.000891	CcSEcCtD
Vinorelbine—Immune system disorder—Methotrexate—colon cancer	1.99e-05	0.000888	CcSEcCtD
Vinorelbine—Dizziness—Fluorouracil—colon cancer	1.99e-05	0.000888	CcSEcCtD
Vinorelbine—Mediastinal disorder—Methotrexate—colon cancer	1.99e-05	0.000886	CcSEcCtD
Vinorelbine—Rash—Irinotecan—colon cancer	1.99e-05	0.000884	CcSEcCtD
Vinorelbine—Dermatitis—Irinotecan—colon cancer	1.98e-05	0.000883	CcSEcCtD
Vinorelbine—Headache—Irinotecan—colon cancer	1.97e-05	0.000878	CcSEcCtD
Vinorelbine—Hypotension—Capecitabine—colon cancer	1.97e-05	0.000877	CcSEcCtD
Vinorelbine—Alopecia—Methotrexate—colon cancer	1.95e-05	0.000869	CcSEcCtD
Vinorelbine—Erythema—Methotrexate—colon cancer	1.92e-05	0.000856	CcSEcCtD
Vinorelbine—Malnutrition—Methotrexate—colon cancer	1.92e-05	0.000856	CcSEcCtD
Vinorelbine—Nausea—Vincristine—colon cancer	1.92e-05	0.000855	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Capecitabine—colon cancer	1.92e-05	0.000855	CcSEcCtD
Vinorelbine—Vomiting—Fluorouracil—colon cancer	1.92e-05	0.000854	CcSEcCtD
Vinorelbine—Rash—Fluorouracil—colon cancer	1.9e-05	0.000847	CcSEcCtD
Vinorelbine—Dermatitis—Fluorouracil—colon cancer	1.9e-05	0.000846	CcSEcCtD
Vinorelbine—Paraesthesia—Capecitabine—colon cancer	1.89e-05	0.000843	CcSEcCtD
Vinorelbine—Headache—Fluorouracil—colon cancer	1.89e-05	0.000841	CcSEcCtD
Vinorelbine—Dyspnoea—Capecitabine—colon cancer	1.88e-05	0.000837	CcSEcCtD
Vinorelbine—Nausea—Irinotecan—colon cancer	1.87e-05	0.000833	CcSEcCtD
Vinorelbine—Back pain—Methotrexate—colon cancer	1.86e-05	0.000828	CcSEcCtD
Vinorelbine—ABCB1—lymph node—colon cancer	1.85e-05	0.003	CbGeAlD
Vinorelbine—Decreased appetite—Capecitabine—colon cancer	1.83e-05	0.000816	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Capecitabine—colon cancer	1.82e-05	0.00081	CcSEcCtD
Vinorelbine—Fatigue—Capecitabine—colon cancer	1.82e-05	0.000809	CcSEcCtD
Vinorelbine—Constipation—Capecitabine—colon cancer	1.8e-05	0.000802	CcSEcCtD
Vinorelbine—Pain—Capecitabine—colon cancer	1.8e-05	0.000802	CcSEcCtD
Vinorelbine—Nausea—Fluorouracil—colon cancer	1.79e-05	0.000798	CcSEcCtD
Vinorelbine—Ill-defined disorder—Methotrexate—colon cancer	1.78e-05	0.000794	CcSEcCtD
Vinorelbine—Anaemia—Methotrexate—colon cancer	1.78e-05	0.000791	CcSEcCtD
Vinorelbine—Feeling abnormal—Capecitabine—colon cancer	1.74e-05	0.000773	CcSEcCtD
Vinorelbine—Malaise—Methotrexate—colon cancer	1.73e-05	0.000772	CcSEcCtD
Vinorelbine—Vertigo—Methotrexate—colon cancer	1.73e-05	0.000769	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Capecitabine—colon cancer	1.72e-05	0.000767	CcSEcCtD
Vinorelbine—Leukopenia—Methotrexate—colon cancer	1.72e-05	0.000766	CcSEcCtD
Vinorelbine—Cough—Methotrexate—colon cancer	1.68e-05	0.000747	CcSEcCtD
Vinorelbine—Urticaria—Capecitabine—colon cancer	1.67e-05	0.000745	CcSEcCtD
Vinorelbine—Abdominal pain—Capecitabine—colon cancer	1.67e-05	0.000742	CcSEcCtD
Vinorelbine—Body temperature increased—Capecitabine—colon cancer	1.67e-05	0.000742	CcSEcCtD
Vinorelbine—Chest pain—Methotrexate—colon cancer	1.64e-05	0.000729	CcSEcCtD
Vinorelbine—Arthralgia—Methotrexate—colon cancer	1.64e-05	0.000729	CcSEcCtD
Vinorelbine—Myalgia—Methotrexate—colon cancer	1.64e-05	0.000729	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	1.63e-05	0.000724	CcSEcCtD
Vinorelbine—Discomfort—Methotrexate—colon cancer	1.62e-05	0.00072	CcSEcCtD
Vinorelbine—Anaphylactic shock—Methotrexate—colon cancer	1.57e-05	0.000699	CcSEcCtD
Vinorelbine—Infection—Methotrexate—colon cancer	1.56e-05	0.000694	CcSEcCtD
Vinorelbine—Hypersensitivity—Capecitabine—colon cancer	1.55e-05	0.000691	CcSEcCtD
Vinorelbine—Nervous system disorder—Methotrexate—colon cancer	1.54e-05	0.000685	CcSEcCtD
Vinorelbine—Thrombocytopenia—Methotrexate—colon cancer	1.54e-05	0.000684	CcSEcCtD
Vinorelbine—Skin disorder—Methotrexate—colon cancer	1.52e-05	0.000678	CcSEcCtD
Vinorelbine—Asthenia—Capecitabine—colon cancer	1.51e-05	0.000673	CcSEcCtD
Vinorelbine—Anorexia—Methotrexate—colon cancer	1.5e-05	0.000666	CcSEcCtD
Vinorelbine—Pruritus—Capecitabine—colon cancer	1.49e-05	0.000664	CcSEcCtD
Vinorelbine—Hypotension—Methotrexate—colon cancer	1.47e-05	0.000653	CcSEcCtD
Vinorelbine—Diarrhoea—Capecitabine—colon cancer	1.44e-05	0.000642	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Methotrexate—colon cancer	1.43e-05	0.000636	CcSEcCtD
Vinorelbine—Paraesthesia—Methotrexate—colon cancer	1.41e-05	0.000627	CcSEcCtD
Vinorelbine—Dyspnoea—Methotrexate—colon cancer	1.4e-05	0.000623	CcSEcCtD
Vinorelbine—Dizziness—Capecitabine—colon cancer	1.39e-05	0.00062	CcSEcCtD
Vinorelbine—Decreased appetite—Methotrexate—colon cancer	1.36e-05	0.000607	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Methotrexate—colon cancer	1.35e-05	0.000603	CcSEcCtD
Vinorelbine—Fatigue—Methotrexate—colon cancer	1.35e-05	0.000602	CcSEcCtD
Vinorelbine—Pain—Methotrexate—colon cancer	1.34e-05	0.000597	CcSEcCtD
Vinorelbine—Vomiting—Capecitabine—colon cancer	1.34e-05	0.000597	CcSEcCtD
Vinorelbine—Rash—Capecitabine—colon cancer	1.33e-05	0.000592	CcSEcCtD
Vinorelbine—Dermatitis—Capecitabine—colon cancer	1.33e-05	0.000591	CcSEcCtD
Vinorelbine—Headache—Capecitabine—colon cancer	1.32e-05	0.000588	CcSEcCtD
Vinorelbine—Feeling abnormal—Methotrexate—colon cancer	1.29e-05	0.000576	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Methotrexate—colon cancer	1.28e-05	0.000571	CcSEcCtD
Vinorelbine—Nausea—Capecitabine—colon cancer	1.25e-05	0.000557	CcSEcCtD
Vinorelbine—Urticaria—Methotrexate—colon cancer	1.25e-05	0.000555	CcSEcCtD
Vinorelbine—Abdominal pain—Methotrexate—colon cancer	1.24e-05	0.000552	CcSEcCtD
Vinorelbine—Body temperature increased—Methotrexate—colon cancer	1.24e-05	0.000552	CcSEcCtD
Vinorelbine—Hypersensitivity—Methotrexate—colon cancer	1.16e-05	0.000515	CcSEcCtD
Vinorelbine—Asthenia—Methotrexate—colon cancer	1.13e-05	0.000501	CcSEcCtD
Vinorelbine—Pruritus—Methotrexate—colon cancer	1.11e-05	0.000494	CcSEcCtD
Vinorelbine—Diarrhoea—Methotrexate—colon cancer	1.07e-05	0.000478	CcSEcCtD
Vinorelbine—Dizziness—Methotrexate—colon cancer	1.04e-05	0.000462	CcSEcCtD
Vinorelbine—Vomiting—Methotrexate—colon cancer	9.97e-06	0.000444	CcSEcCtD
Vinorelbine—Rash—Methotrexate—colon cancer	9.89e-06	0.00044	CcSEcCtD
Vinorelbine—Dermatitis—Methotrexate—colon cancer	9.88e-06	0.00044	CcSEcCtD
Vinorelbine—Headache—Methotrexate—colon cancer	9.83e-06	0.000438	CcSEcCtD
Vinorelbine—Nausea—Methotrexate—colon cancer	9.32e-06	0.000415	CcSEcCtD
